PF-AtlasDrugs › Baofeikang Granule

Baofeikang Granule

Idiopathic Pulmonary Fibrosis

Clinical trials
1
Developer
Beijing Municipal Science & Technology Commission

Overview

Baofeikang Granule is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.

Baofeikang Granule clinical trials

Explore related

Medical disclaimer. This page summarizes research about Baofeikang Granule for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.